Thermo Fisher to Validate GMU's Protein Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it will work with researchers at George Mason University to validate protein biomarkers GMU discovered using Thermo Fisher’s mass spectrometry technology.
 
Scientists at GMU’s Center for Applied Proteomics and Molecular Medicine (CAPMM) will use Thermo Fisher’s Quantum Ultra triple quadrupole mass spectrometers to discover cancer biomarkers, which the company will cross-validate at its Biomarker Research Initiatives in Mass Spectrometry Center.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.